JDRF T1D Fund has made an undisclosed investment in TetraGenetics. Based in Arlington, Massachusetts, TetraGenetics is a biopharmaceutical company developing new treatments for autoimmune diseases. Read more >>
The field of electronic eyeglasses is another exciting example of how advanced technology can help manage conditions that once…
read moreNewly appointed COO, CPO, CTO and Interim GC to accelerate Carbonite’s integration of Webroot. Results-driven leadership team to deliver…
read moreXylyx Bio, a pioneer in physiomimetic biomaterials, today announced that it has joined the Advanced Regenerative Manufacturing Institute (ARMI),…
read moreEach month as part of StartHub Startups to Watch Program we connect with the winning company to learn more…
read moreCorbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics…
read moreBritny can see thanks to special glasses called Esight. They help her focus and can make images 20 times…
read moreToday the Financial Solutions Lab (FinLab) at the Center for Financial Services Innovation (CFSI) with founding partner JPMorgan Chase…
read moreWayne County Emergency Management has partnered with Regroup, a mass notification provider to ensure that residents and visitors to…
read moreThe Boston Business Journal today announced its annual Best Places to Work honorees — 80 companies in the Greater…
read moreThis week on Growing Greater we learn of rare and serious systemic autoimmune condition known as dermatomyositis. We learn…
read more